The Global Burden of Cancer Is Rising—But Not Equally
Published in Cancer
Cancer remains one of the leading causes of morbidity and mortality worldwide. But how is the burden evolving—and where is it growing the fastest?
In this large-scale analysis from the Global Burden of Disease (GBD) 2019 Study, published in JAMA Oncology, we gain a comprehensive picture of global cancer trends across 204 countries over the past decade.
🌍 Study Overview
- Data from 204 countries and territories
- Analysis period: 2010–2019
- Outcomes measured:
- Incidence
- Mortality
- Years of life lost (YLLs)
- Years lived with disability (YLDs)
- Disability-adjusted life years (DALYs)
📊 Key Findings
• Global cancer burden is increasing
– 23.6 million new cases in 2019
– 10 million deaths
– 250 million DALYs
• Significant rise over the decade
– Cases ↑ 26.3%
– Deaths ↑ 20.9%
– DALYs ↑ 16%
• Cancer is now the 2nd leading cause of death and disease burden globally (after cardiovascular diseases)
• Disparities by Socio-demographic Index (SDI)
– High SDI countries: highest incidence
– Middle SDI countries: highest mortality and DALYs
– Low & low-middle SDI: fastest growth in cases and deaths
• Disability burden is increasing
– Greater contribution of YLDs to DALYs in higher SDI regions
💡 Key Takeaways
This study highlights a critical reality:
➡️ Cancer burden is not only increasing—but shifting
- Low-resource settings are experiencing the fastest growth
- Mortality remains disproportionately high in middle SDI regions
- Survivorship—and thus disability burden—is rising in high SDI countries
⚖️ What This Means for Global Health
- Urgent need for equitable cancer control strategies
- Strengthening early detection and treatment access in lower SDI regions
- Expanding focus beyond survival to include quality of life and disability
- Data-driven policy is essential to address regional disparities
📄 Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups (2010–2019)
JAMA Oncology (2022)
DOI: 10.1001/jamaoncol.2021.6987
Global Burden of Disease 2019 Cancer Collaboration
Article links:
https://pubmed.ncbi.nlm.nih.gov/34967848/
https://jamanetwork.com/journals/jamaoncology/fullarticle/2787350
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in